Compare J.B.Chemicals with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SUN PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SUN PHARMA J.B.CHEMICALS/
SUN PHARMA
 
P/E (TTM) x 14.6 20.5 71.5% View Chart
P/BV x 2.6 2.2 120.7% View Chart
Dividend Yield % 0.4 0.7 61.0%  

Financials

 J.B.CHEMICALS   SUN PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
SUN PHARMA
Mar-19
J.B.CHEMICALS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs363679 53.5%   
Low Rs255375 67.9%   
Sales per share (Unadj.) Rs169.1121.1 139.6%  
Earnings per share (Unadj.) Rs16.613.4 124.1%  
Cash flow per share (Unadj.) Rs23.420.7 113.2%  
Dividends per share (Unadj.) Rs2.002.75 72.7%  
Dividend yield (eoy) %0.60.5 124.0%  
Book value per share (Unadj.) Rs172.5172.6 99.9%  
Shares outstanding (eoy) m83.572,399.26 3.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.84.4 42.0%   
Avg P/E ratio x18.639.4 47.2%  
P/CF ratio (eoy) x13.225.5 51.8%  
Price / Book Value ratio x1.83.1 58.7%  
Dividend payout %12.020.6 58.6%   
Avg Mkt Cap Rs m25,8271,264,650 2.0%   
No. of employees `0003.817.5 21.6%   
Total wages/salary Rs m2,51159,671 4.2%   
Avg. sales/employee Rs Th3,747.416,608.1 22.6%   
Avg. wages/employee Rs Th665.73,409.6 19.5%   
Avg. net profit/employee Rs Th367.81,833.8 20.1%   
INCOME DATA
Net Sales Rs m14,135290,659 4.9%  
Other income Rs m36610,255 3.6%   
Total revenues Rs m14,501300,914 4.8%   
Gross profit Rs m2,17863,076 3.5%  
Depreciation Rs m57017,533 3.2%   
Interest Rs m355,553 0.6%   
Profit before tax Rs m1,94050,246 3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m5526,009 9.2%   
Profit after tax Rs m1,38732,093 4.3%  
Gross profit margin %15.421.7 71.0%  
Effective tax rate %28.512.0 238.1%   
Net profit margin %9.811.0 88.9%  
BALANCE SHEET DATA
Current assets Rs m10,470310,692 3.4%   
Current liabilities Rs m2,749173,396 1.6%   
Net working cap to sales %54.647.2 115.6%  
Current ratio x3.81.8 212.6%  
Inventory Days Days5599 55.7%  
Debtors Days Days78112 69.6%  
Net fixed assets Rs m5,811232,477 2.5%   
Share capital Rs m1672,399 7.0%   
"Free" reserves Rs m14,248411,691 3.5%   
Net worth Rs m14,416414,091 3.5%   
Long term debt Rs m015,226 0.0%   
Total assets Rs m17,649646,938 2.7%  
Interest coverage x56.610.0 563.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 178.3%   
Return on assets %8.15.8 138.5%  
Return on equity %9.67.8 124.2%  
Return on capital %13.710.2 134.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16466,025 9.3%   
Fx outflow Rs m1,33438,610 3.5%   
Net fx Rs m4,82927,415 17.6%   
CASH FLOW
From Operations Rs m1,23121,965 5.6%  
From Investments Rs m-208-6,813 3.1%  
From Financial Activity Rs m-595-27,305 2.2%  
Net Cashflow Rs m427-8,442 -5.1%  

Share Holding

Indian Promoters % 55.4 63.7 87.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.1 66.1%  
FIIs % 3.9 23.0 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 8.3 445.8%  
Shareholders   30,437 133,026 22.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   STERLING BIOTECH  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  PFIZER  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views on News

SUN PHARMA Surges by 11%; BSE HEALTHCARE Index Up 4.3% (Market Updates)

Apr 3, 2020 | Updated on Apr 3, 2020

SUN PHARMA share price has surged by 11% and its current market price is Rs 385. The BSE HEALTHCARE is up by 4.3%. The top gainers in the BSE HEALTHCARE Index are SUN PHARMA (up 11.4%) and LUPIN (up 11.5%). The top losers are ALKEM LABORATORIES (down 0.3%) and GSK PHARMA (down 0.4%).

J.B.CHEMICALS Plunges by 10%; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Apr 3, 2020 | Updated on Apr 3, 2020

J.B.CHEMICALS share price has plunged by 10% and its current market price is Rs 492. The BSE HEALTHCARE is up by 1.1%. The top gainers in the BSE HEALTHCARE Index are APOLLO HOSPITALS (up 7.1%) and CIPLA (up 6.8%). The top losers is J.B.CHEMICALS (down 10.1%)..

PIRAMAL ENTERPRISES Plunges by 6%; BSE HEALTHCARE Index Up 3.7% (Market Updates)

Apr 3, 2020 | Updated on Apr 3, 2020

PIRAMAL ENTERPRISES share price has plunged by 6% and its current market price is Rs 938. The BSE HEALTHCARE is up by 3.7%. The top gainers in the BSE HEALTHCARE Index are LUPIN (up 10.4%) and SUN PHARMA (up 9.2%). The top losers are PIRAMAL ENTERPRISES (down 5.8%) and J.B.CHEMICALS (down 7.0%).

ADVANCED ENZYME TECHNOLOGIES Plunges by 5%; BSE HEALTHCARE Index Up 0.6% (Market Updates)

Apr 3, 2020 | Updated on Apr 3, 2020

ADVANCED ENZYME TECHNOLOGIES share price has plunged by 5% and its current market price is Rs 133. The BSE HEALTHCARE is up by 0.6%. The top gainers in the BSE HEALTHCARE Index are FDC LTD. (up 6.1%) and SHILPA MEDICARE (up 5.0%). The top losers are ADVANCED ENZYME TECHNOLOGIES (down 5.3%) and J.B.CHEMICALS (down 7.8%).

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Apr 3, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS